The UTHealth Medical-Legal Partnership: Improving Health by Addressing Health-Harming Legal Needs

• Sponsor: The University of Texas Health Science Center, Houston (Other)
• Overall Status: Completed
• CT.gov ID: NCT03364543
• Collaborator: (none)
• Enrollment: 911
• Locations: 2
• Actual Duration (Months): 9.6
• Patients Per Site: 455.5
• Patients Per Site Per Month: 47.6

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the acceptability, feasibility, and preliminary effectiveness of the UTHealth medical-legal partnerships (MLP) against usual care.

Condition or Disease	Intervention/Treatment	Phase
Social Determinants of Health	Other: Access to the Medical-Legal Partnership Group; Other: Access to social worker and a community worker

Study Design

• Study Type: Observational
• Actual Enrollment: 911 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: The UTHealth Medical-Legal Partnership: Improving Health by Addressing Health-Harming Legal Needs
• Actual Study Start Date: Apr 16, 2018
• Actual Primary Completion Date: Feb 1, 2019
• Actual Study Completion Date: Feb 1, 2019

Arms and Interventions

Arm	Intervention/Treatment
Medical-Legal Partnership Group The Medical-Legal Partnership Group are lawyers in clinics who address health-harming legal needs. This group will also have access to access to a social worker and a community worker.	Other: Access to the Medical-Legal Partnership Group; The Medical-Legal Partnership Group are lawyers in clinics who address health-harming legal needs.; Other: Access to social worker and a community worker; Access to social worker and a community worker, but no systematic process for addressing health-harming legal needs.
Usual Care Access to a social worker and a community worker, but no systematic process for addressing health-harming legal needs.	Other: Access to social worker and a community worker; Access to social worker and a community worker, but no systematic process for addressing health-harming legal needs.

Outcome Measures

Primary Outcome Measures

1. Number of participants who had an emergency department visit [6 months]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• English- or Spanish- speaking

• screen positive for health-harming legal needs (HHLNs)

Exclusion Criteria:

• Those unable or unwilling to consent to legal services

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	The University of Texas Health Science Center at Houston	Houston	Texas	United States	77030
2	UTHealth Comprehensive Sickle Cell Center	Houston	Texas	United States	77030

Sponsors and Collaborators

• The University of Texas Health Science Center, Houston

Investigators

• Principal Investigator: Winston Liaw, The University of Texas Health Science Center, Houston

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Winston Liaw, Associate Professor, The University of Texas Health Science Center, Houston
• ClinicalTrials.gov Identifier: NCT03364543
• Other Study ID Numbers: 2017-048
• First Posted: Dec 6, 2017
• Last Update Posted: Nov 6, 2020
• Last Verified: Nov 1, 2020

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Study Results

No Results Posted as of Nov 6, 2020